Table 3 The baseline optical coherence tomography markers of patients with vision loss of more than 15 ETDRS letters from baseline to months 3 and 12
| Â | Vision loss in month 3 | Vision loss in month 12 | ||||
|---|---|---|---|---|---|---|
15 ≥ ETDRS letters N (%) | 15 < ETDRS letters N (%) | P†| 15 ≥ ETDRS letters N (%) | 15 < ETDRS letters N (%) | P†| |
SIPED | Â | Â | Â | Â | Â | Â |
 No | 31 (96.9%) | 1 (3.1%) | 0.837 | 29 (90.6%) | 3 (9.4%) | 0.828 |
 Yes | 48 (96.0%) | 2 (4.0%) |  | 46 (92.0%) | 4 (8.0%) |  |
SHRM | Â | Â | Â | Â | Â | Â |
 No | 11 (91.7%) | 1 (8.3%) | 0.382 | 12 (100.0%) | 0 (0.0%) | 0.586 |
 Yes | 68 (97.1%) | 2 (2.9%) |  | 63 (90.0%) | 7 (10.0%) |  |
SRF | Â | Â | Â | Â | Â | Â |
 No | 12 (92.3%) | 1 (7.7%) | 0.408 | 11 (84.6%) | 2 (15.4%) | 0.306 |
 Yes | 67 (97.1%) | 2 (2.9%) |  | 64 (92.8%) | 5 (7.2%) |  |
IRF | Â | Â | Â | Â | Â | Â |
 No | 34 (100.0%) | 0 (0.0%) | 0.263 | 34 (100.0%) | 0 (0.0%) | 0.038 |
 Yes | 45 (93.8%) | 3 (6.3%) |  | 41 (85.4%) | 7 (14.6%) |  |
HRF (subretinal) | Â | Â | Â | Â | Â | Â |
 No | 17 (94.4%) | 1 (5.6%) | 0.53 | 15 (83.3%) | 3 (16.7%) | 0.175 |
 Yes | 62 (96.9%) | 2 (3.1%) |  | 60 (93.8%) | 4 (6.3%) |  |
HRF (intraretinal) | Â | Â | Â | Â | Â | Â |
 No | 20 (100.0%) | 0 (0.0%) | 0.573 | 20 (100.0%) | 0 (0.0%) | 0.186 |
 Yes | 59 (95.2%) | 3 (4.8%) |  | 55 (88.7%) | 7 (11.3%) |  |
SDD | Â | Â | Â | Â | Â | Â |
 No | 64 (97.0%) | 2 (3.0%) | 0.483 | 61 (92.4%) | 5 (7.6%) | 0.618 |
 Yes | 15 (93.8%) | 1 (6.3%) |  | 14 (87.5%) | 2 (12.5%) |  |
Pre-choroidal cleft | Â | Â | Â | Â | Â | Â |
 No | 76 (96.2%) | 3 (3.8%) | >0.99 | 72 (91.1%) | 7 (8.9%) | >0.99 |
 Yes | 3 (100.0%) | 0 (0.0%) |  | 3 (100.0%) | 0 (0.0%) |  |